Effect of Time to Minimally Invasive Esophagectomy After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma

被引：0
|
作者：
Nguyen Vo Vinh Loc
Nguyen Lam Vuong
Lam Viet Trung
Tran Thien Trung
机构：
[1] University of Medicine and Pharmacy at Ho Chi Minh City,Department of General Surgery, Faculty of Medicine
[2] Cho Ray Hospital,Digestive Surgery Department
[3] University of Medicine and Pharmacy at Ho Chi Minh City,Department of Medical Statistics and Informatics, Faculty of Public Health
来源：
Journal of Gastrointestinal Cancer | 2023年 / 54卷
关键词：
Esophageal cancer; Time to surgery; Neoadjuvant chemotherapy; Esophagectomy;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1240 / 1251
页数：11
相关论文
共 50 条
  • [1] Effect of Time to Minimally Invasive Esophagectomy After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
    Loc, Nguyen Vo Vinh
    Vuong, Nguyen Lam
    Trung, Lam Viet
    Trung, Tran Thien
    JOURNAL OF GASTROINTESTINAL CANCER, 2023, 54 (04) : 1240 - 1251
  • [2] Neoadjuvant chemotherapy followed by minimally invasive esophagectomy is safe and feasible for treatment of esophageal squamous cell carcinoma
    Ma, Shaohua
    Yan, Tiansheng
    Liu, Dandan
    Wang, Keyi
    Wang, Jingdi
    Song, Jintao
    Wang, Tong
    He, Wei
    Bai, Jie
    Jin, Liang
    Chen, Xiaoxin
    THORACIC CANCER, 2018, 9 (02) : 310 - 315
  • [3] Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hosogi, Hisahiro
    Yoshida, Shinya
    Sakaguchi, Masazumi
    Kanaya, Seiichiro
    JOURNAL OF GASTROINTESTINAL SURGERY, 2023, 27 (12) : 3040 - 3042
  • [4] Neoadjuvant Chemoradiotherapy Followed by Minimally Invasive Esophagectomy for Borderline Resectable Esophageal Squamous Cell Carcinoma
    Hisahiro Hosogi
    Shinya Yoshida
    Masazumi Sakaguchi
    Seiichiro Kanaya
    Journal of Gastrointestinal Surgery, 2023, 27 : 3040 - 3042
  • [5] Perioperative Outcomes of Minimally Invasive Esophagectomy After Neoadjuvant Immunotherapy for Patients With Locally Advanced Esophageal Squamous Cell Carcinoma
    Cheng, Jiahan
    Guo, Minzhang
    Yang, Yushang
    Liu, Yilin
    Hu, Weipeng
    Shang, Qixin
    Li, Chuan
    Xia, Liang
    Wang, Yun
    Wang, Wenping
    Tian, Dong
    Yuan, Yong
    Hu, Yang
    Chen, Longqi
    FRONTIERS IN IMMUNOLOGY, 2022, 13
  • [6] Minimally invasive esophagectomy for esophageal squamous cell carcinoma in elderly patients
    Li, Yong
    Wang, Pei
    Li, Xiaohui
    Shi, Gongning
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (07): : 13007 - 13013
  • [7] Minimally invasive versus open McKeown esophagectomy for patients with esophageal squamous cell carcinoma after neoadjuvant PD-1 inhibitor plus chemotherapy
    Chen, Qiuming
    Mo, Shaocong
    Aizemaiti, Rusidanmu
    Cheng, Jun
    Wu, Ziheng
    Ye, Peng
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [8] Cost-Effectiveness of Minimally Invasive Esophagectomy for Esophageal Squamous Cell Carcinoma
    Chao-Yu Liu
    Chen-Sung Lin
    Chih-Shiun Shih
    Yuh-An Huang
    Chia-Chuan Liu
    Chih-Tao Cheng
    World Journal of Surgery, 2018, 42 : 2522 - 2529
  • [9] Cost-Effectiveness of Minimally Invasive Esophagectomy for Esophageal Squamous Cell Carcinoma
    Liu, Chao-Yu
    Lin, Chen-Sung
    Shih, Chih-Shiun
    Huang, Yuh-An
    Liu, Chia-Chuan
    Cheng, Chih-Tao
    WORLD JOURNAL OF SURGERY, 2018, 42 (08) : 2522 - 2529
  • [10] Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy followed by minimally invasive esophagectomy for locally advanced esophageal squamous cell carcinoma: a prospective multicenter randomized clinical trial
    Tang, H.
    Wang, H.
    Fang, Y.
    Zhu, J. Y.
    Yin, J.
    Shen, Y. X.
    Zeng, Z. C.
    Xiang, D. X.
    Hou, Y. Y.
    Du, M.
    Lian, C. H.
    Zhao, Q.
    Jiang, H. J.
    Gong, L.
    Li, Z. G.
    Liu, J.
    Xie, D. Y.
    Li, W. F.
    Chen, C.
    Zheng, B.
    Chen, K. N.
    Dai, L.
    Liao, Y. D.
    Li, K.
    Li, H. C.
    Zhao, N. Q.
    Tan, L. J.
    ANNALS OF ONCOLOGY, 2023, 34 (02) : 163 - 172
12345